zolpidem has been researched along with l 655,708 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JM; Dayer, CA; He, X; Huang, Q; Liu, R; Ma, C; McKernan, R; Wenger, GR; Yu, S | 1 |
| Atack, JR; Carling, RW; Castro, JL; Cook, SM; Dawson, GR; Ferris, P; Isted, C; Leeson, PD; McKernan, RM; Moore, KW; O'Connor, D; Quirk, K; Street, LJ; Thomas, S; Thompson, SA; Wafford, KA; Wild, D | 1 |
| Atack, JR; Bromidge, FA; Carling, RW; Castro, JL; Cook, S; Dawson, GR; Jelley, RA; MacLeod, AM; Marshall, G; McKernan, RM; Moore, KW; Pike, A; Pillai, GV; Reeve, AJ; Seabrook, GR; Sohal, B; Sternfeld, F; Street, LJ; Thompson, SA; Wafford, KA | 1 |
3 other study(ies) available for zolpidem and l 655,708
| Article | Year |
|---|---|
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Topics: Animals; Benzodiazepines; Carbolines; Cell Line; Columbidae; Conditioning, Operant; Crystallography, X-Ray; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quinolones; Radioligand Assay; Receptors, GABA-A; Saimiri; Stereoisomerism; Structure-Activity Relationship | 2000 |
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
Topics: Animals; Anti-Anxiety Agents; Binding, Competitive; Biological Availability; Cell Line; GABA-A Receptor Agonists; Humans; Magnetic Resonance Spectroscopy; Maze Learning; Oocytes; Patch-Clamp Techniques; Phthalazines; Radioligand Assay; Rats; Receptors, GABA-A; Recombinant Proteins; Structure-Activity Relationship; Triazoles; Xenopus | 2004 |
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site.
Topics: Administration, Oral; Animals; Binding Sites; Biological Availability; Cell Line; Female; GABA-A Receptor Agonists; Humans; Isoxazoles; Male; Maze Learning; Oocytes; Patch-Clamp Techniques; Phthalazines; Protein Subunits; Radioligand Assay; Rats; Structure-Activity Relationship; Triazoles; Xenopus laevis | 2004 |